Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
Conditions:   Cutaneous T Cell Lymphoma;   Fungoides Mycosis Sezary Syndrome Interventions:   Drug: Pembrolizumab;   Drug: Mogamulizumab Sponsors:   University of Michigan Rogel Cancer Center;   Merck Sharp & Dohme LLC;   Hoosier Cancer Research Network Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2023 Category: Research Source Type: clinical trials

Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and S ézary Syndrome
Conditions:   Mycosis Fungoides;   Sezary Syndrome;   Mycosis Fungoides/Sezary Syndrome Intervention:   Drug: Tulmimetostat Sponsors:   Washington University School of Medicine;   MorphoSys AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials